Genesis Healthcare Inc. (GEN) Receives Average Recommendation of “Hold” from Brokerages
Shares of Genesis Healthcare Inc. (NYSE:GEN) have received a consensus rating of “Hold” from the five brokerages that are currently covering the company. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $2.52.
Separately, Bank of America Corp. set a $1.80 target price on shares of Genesis Healthcare and gave the company a “sell” rating in a research report on Monday, September 19th.
Shares of Genesis Healthcare (NYSE:GEN) traded up 1.95% during midday trading on Monday, hitting $2.62. 56,000 shares of the stock were exchanged. Genesis Healthcare has a 12 month low of $1.38 and a 12 month high of $5.75. The stock’s market cap is $235.78 million. The firm’s 50-day moving average is $2.67 and its 200-day moving average is $2.21.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/genesis-healthcare-inc-gen-receives-average-recommendation-of-hold-from-brokerages.html
Genesis Healthcare (NYSE:GEN) last announced its quarterly earnings results on Thursday, August 4th. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.27. The firm had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same period in the previous year, the firm earned $0.14 earnings per share. The business’s revenue for the quarter was up 1.3% on a year-over-year basis. Equities research analysts predict that Genesis Healthcare will post ($1.49) earnings per share for the current year.
Large investors have recently bought and sold shares of the stock. Columbia Pacific Advisors LLC boosted its position in Genesis Healthcare by 24.6% in the second quarter. Columbia Pacific Advisors LLC now owns 4,026,928 shares of the company’s stock worth $7,128,000 after buying an additional 795,272 shares in the last quarter. BlackRock Fund Advisors boosted its position in Genesis Healthcare by 3.7% in the second quarter. BlackRock Fund Advisors now owns 994,928 shares of the company’s stock worth $1,761,000 after buying an additional 35,811 shares in the last quarter. Vanguard Group Inc. boosted its position in Genesis Healthcare by 0.9% in the second quarter. Vanguard Group Inc. now owns 864,806 shares of the company’s stock worth $1,531,000 after buying an additional 7,773 shares in the last quarter. State Street Corp boosted its position in Genesis Healthcare by 53.8% in the second quarter. State Street Corp now owns 622,856 shares of the company’s stock worth $1,102,000 after buying an additional 217,974 shares in the last quarter. Finally, Forward Management LLC boosted its position in Genesis Healthcare by 16.2% in the first quarter. Forward Management LLC now owns 564,631 shares of the company’s stock worth $1,310,000 after buying an additional 78,875 shares in the last quarter. 8.07% of the stock is owned by institutional investors.
Genesis Healthcare Company Profile
Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services.
Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.